BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

BCR-ABL Tests Market Report Overview

The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region – Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML).

BCR-ABL Tests Market Outlook 2023-2023 ($ Million)

Buy the Full Report for More Insights on the BCR-ABL Tests Market Forecast
Download a Free Report Sample

The BCR-ABL Tests market research report explains the market behavior, which will help identify quantitative market trends within the In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the BCR-ABL Tests market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.

BCR-ABL Tests Market Dynamics

The BCR-ABL Test market is expected to grow in the coming years owing to a dramatic increase in the volume of NAATs and rising incidence of CML and ALL. In addition, improved accessibility to BCR-ABL TKIs in emerging economies and technological advancements will further boost the market growth. However, social inequalities that limit access to tests and the associated treatments in developing countries may limit the market growth in the forecast period.

BCR-ABL Tests Market Segments

The key segments in the BCR-ABL Tests market are BCR-ABL Tests and Next Generation Sequencing (NGS) Tests. In 2023, the BCR-ABL Tests segment dominated the market. The BCR-ABL Test is sub-segmented into BCR-ABL In Situ Hybridisation Tests and BCR-ABL Nucleic Acid Amplification Tests (NAATs). Within these, BCR-ABL NAATs had the highest market share in 2023.

BCR-ABL Tests Market Analysis by Segments, 2023 (%)

Buy The Full Report to Know More About the BCR-ABL Tests Market Segments
Download a Free Report Sample

BCR-ABL Tests Market Segmentation by Regions

The key regions in the BCR-ABL Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America dominated the BCR-ABL Tests market, and the region is expected to retain its position during the forecast period. This growth is attributed to a rise in the incidence of CML and ALL and steady therapies.

BCR-ABL Tests Market Analysis by Regions, 2023 (%)
Buy The Full Report for More Regional Insights into the BCR-ABL Tests Market
Download a Free Report Sample

BCR-ABL Tests Market – Competitive Landscape

A few of the key companies in the BCR-ABL test market are:

• Abbott Laboratories
• Qiagen NV
• Agilent Technologies Inc
• Asuragen Inc
• Thermo Fisher Scientific Inc

In 2023, Abbott Laboratories accounted for the highest BCR-ABL Tests market share, followed by Asuragen Inc.

BCR-ABL Tests Market Analysis by Companies, 2023 (%)

Buy The Full Report for More Company Insights into the BCR-ABL Tests Market
Download a Free Report Sample

Segments Covered in this Report

BCR-ABL Tests Segment Outlook ($ Million, 2015-2033)

• BCR-ABL Tests
• Next Generation Sequencing (NGS) Tests

BCR-ABL Tests Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are –

Currently marketed BCR-ABL Tests market and evolving competitive landscape –

• Insightful review of the key industry trends.
• Annualized total BCR-ABL Tests market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights –

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the BCR-ABL Tests market.
• Competitive dynamics insights and trends provided for the BCR-ABL Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Sysmex Corp, Bio-Techne Corp, Danaher Corp, Bio-Rad Laboratories Inc, Qiagen NV, Agilent Technologies Inc, Illumina Inc, Thermo Fisher Scientific Inc, Takara Bio Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This report provides:

• Insightful review of the key industry trends.
• Annualized total BCR-ABL Tests market revenue by segment and market outlooks.
• Market-level data on units, average selling prices, and market values.
• Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the BCR-ABL Tests market.
• Competitive dynamics insights and trends provided for the BCR-ABL Tests market.
• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on BCR-ABL Tests.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving BCR-ABL Tests.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the BCR-ABL Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific BCR-ABL Test market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.